| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 360 | $100 | $35.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 320 | $70 | $21.6K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 260 | $60 | $16.5K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $130 | $16K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 130 | $60 | $8.3K |
| 76775 | A retroperitoneal ultrasound is a noninvasive procedure used to assess the body parts within the abdomen (i.e. Kidneys, urinary bladder, and aorta). This particular CPT code is used when the… | 170 | $50 | $7.8K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 120 | $60 | $7.7K |
| J9030 | BCG live intravesical instillation, 1 mg | 3,850 | $1 | $7.7K |
| 52235 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 30 | $240 | $7K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 50 | $150 | $6.9K |